|
Company:
|
OPGEN INC (OPGN)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
11/12/2021
|
|
CIK:
|
0001293818
|
|
Address:
|
9717 KEY WEST AVENUE
SUITE 100
|
|
City, State, Zip:
|
ROCKVILLE, Maryland 20850
|
|
Telephone:
|
301-869-9683
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$1.80
|
Change:
0.00 (0.00%)
|
Trade Time:
Feb 07
|
Market Cap:
$4.83M
|
|
|
|
|
|
|
Description of Business
|
|
Please refer to the Glossary at the end of this Business section for definitions
or descriptions of scientific, diagnostic, healthcare, regulatory, and
OpGen-specific terms used in this Annual Report.
Overview
OpGen, Inc. (the "Company") is a precision medicine company harnessing the power
of molecular diagnostics and informatics to help combat infectious disease.
Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are
developing and commercializing molecular microbiology solutions helping to guide
clinicians with more rapid and actionable information about life threatening
infections to improve patient outcomes and decrease the spread of infections
caused by multidrug-resistant microorganisms, or MDROs.
|
|
|
|